Skip to main content
. 2021 Jan 1;32(1):30–41. doi: 10.5152/tjg.2020.19877

Figure 4.

Figure 4.

Forest plot for the correlation between sorafenib treatment and overall survival in patients with hepatocellular carcinoma recurrence after liver transplantation; (A) best supportive care versus sorafenib; (B) sorafenib versus best supportive care.